Argenx
ARGX
#485
Rank
NZ$85.65 B
Marketcap
NZ$1,375
Share price
-0.89%
Change (1 day)
14.16%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company